Giovanni Rossi

11PUBLICATIONS
46CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 26, 2025
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.

Lucrezia Barcellini, Simone Nardin, Gianluca Sacco

|Jan 21, 2022
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics.

Emanuele Barabino, Giovanni Rossi, Silvia Pamparino

|Jul 02, 2021
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.

Matteo Bauckneht, Carlo Genova, Giovanni Rossi

|Apr 30, 2021
Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience.

Lavinia Monaco, Maria Gemelli, Irene Gotuzzo

|Apr 03, 2021
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.

Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi

|Feb 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populations.

Lodovica Zullo, Giovanni Rossi, Chiara Dellepiane

Pageof 2

Frequent Collaborators

9 joint publications

Carlo Genova

8 joint publications

Simona Coco

6 joint publications

Marco Tagliamento

5 joint publications

Angela Alama